Immunocore Hldgs Stock (NASDAQ: IMCR) stock price, news, charts, stock research, profile.
Open | $35.00 |
Close | $36.02 |
Volume / Avg. | 283.32K / 783.55K |
Day Range | 34.68 - 36.31 |
52 Wk Range | 33.05 - 76.98 |
Market Cap | $1.80B |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 36 |
Short Interest | 14.15% |
Days to Cover | 5.22 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Immunocore Hldgs (NASDAQ:IMCR) through any online brokerage.
Other companies in Immunocore Hldgs’s space includes: Syndax Pharmaceuticals (NASDAQ:SNDX), Protagonist Therapeutics (NASDAQ:PTGX), Bicycle Therapeutics (NASDAQ:BCYC), BioCryst Pharma (NASDAQ:BCRX) and Novavax (NASDAQ:NVAX).
There is no analysis for Immunocore Hldgs.
Immunocore Hldgs has a consensus price target of $76.94.
The stock price for Immunocore Hldgs (NASDAQ: IMCR) is $36.02 last updated July 3, 2024 at 1:00 PM EDT.
There are no upcoming dividends for Immunocore Hldgs.
Immunocore Hldgs’s Q2 earnings are confirmed for Thursday, August 8, 2024.
There is no upcoming split for Immunocore Hldgs.
Immunocore Hldgs is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.